Jun 11, 2026 01:05AM
Jun 11, 2026 01:05AM
Jun 2, 2026 07:00AM
Jun 2, 2026 01:05AM
May 19, 2026 01:05AM
May 19, 2026 01:05AM
May 15, 2026 12:45PM FDA approves Genentech's Tecentriq for bladder cancer with ctDNA guidance
May 15, 2026 12:45PM
Apr 30, 2026 01:00AM
Apr 22, 2026 08:30AM
Apr 21, 2026 07:15PM
Apr 21, 2026 11:45AM
Apr 21, 2026 01:00AM
Apr 16, 2026 07:00AM Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) Platform
Mar 30, 2026 09:01AM
Mar 30, 2026 09:00AM
Mar 18, 2026 09:00AM
Mar 9, 2026 02:10AM
Mar 6, 2026 08:45AM
Mar 2, 2026 01:10AM
Feb 20, 2026 02:00AM FDA approves Genentech's Venclexta plus acalabrutinib for CLL treatment
Feb 20, 2026 02:00AM
Feb 20, 2026 01:05AM
Feb 16, 2026 01:00AM
Feb 7, 2026 03:40PM
Dec 22, 2025 01:01AM
Dec 22, 2025 01:00AM
Dec 16, 2025 08:30AM Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
Dec 8, 2025 04:30PM
Nov 10, 2025 01:10AM
Nov 3, 2025 09:00AM
Nov 3, 2025 01:00AM
Oct 28, 2025 02:00AM
Oct 23, 2025 09:00AM
Oct 20, 2025 01:05AM Genentech’s Tecentriq Showed Significant Overall and Disease-Free Survival Benefits in Bladder Cancer With ctDNA-Guided Treatment
Oct 20, 2025 01:01AM
Oct 20, 2025 01:00AM
Oct 16, 2025 11:49AM
Oct 16, 2025 11:45AM
Oct 13, 2025 09:00AM
Oct 13, 2025 01:05AM
Oct 2, 2025 06:30PM FDA approves Genentech's Tecentriq plus lurbinectedin for lung cancer
Oct 2, 2025 06:30PM
Sep 24, 2025 02:30AM
Sep 18, 2025 10:00AM
Sep 5, 2025 01:00AM
Aug 30, 2025 10:30AM
Aug 4, 2025 08:00AM
Aug 1, 2025 02:00PM Genentech’s Susvimo Maintains Vision Over Five Years With Two Refills Per Year in People With Wet Age-Related Macular Degeneration (AMD)
Jul 28, 2025 01:00AM

322,901 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All